Josh Reynolds

Wide Receiver

Age: 29
Free Agency: 2024 (UFA)
Accrued Seasons: 7
  • 2024 Salary Cap Charge: $0 (0.00% of cap)
  • 2024 Cash Payout: $0 (0.00% of spending)
  • 2024 Cash to Cap Ratio: 0
  • Contract Value: $6,000,000 ($3,000,000 APY)
  • Fully Guaranteed Money: $2,700,000
  • Contract Ranking: 66/299 at WR

Current Contract

(UFA, signed 2022)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusRoster BonusWorkout BonusOther BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
RegularPer Game
202227$1,200,000$750,000$0$0$50,000$0$1,200,000$2,000,0000.9%
2023 📝
March 17: Roster bonus due
28$1,800,000$750,000$1,000,000$400,000$50,000$250,000$1,000,000$4,000,0001.8%
Total$3,000,000$1,500,000$1,000,000$400,000$100,000$250,000$2,200,000$6,000,000

Contract Notes

Josh Reynolds signed a two year contract with the Detroit Lions worth a base value of $6 million with an additional $4 million in incentives. Reynolds has a $2.7 million guarantee including a $750,000 signing bonus. 2023 roster bonus is due on the 3rd day of the 2023 league year.

Cash Flows

- fully earned money
- unearned or partially earned money
$3M
$6M
20222023
Cash Due$3,000,000$3,500,000
Running Cash$2,500,000$6,000,000
Career Earnings: $13,196,024
Career APY: $1,885,146
Potential Earnings: $11,446,024
Total Guarantees: $6,848,024
Largest Cash Payment: $3,500,000 (2023)
Largest Cap Number: $4,000,000 (2023)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
RamsDraftedExpired20174$3,048,024$762,006$648,024$4,446,024145.9%$1,111,506
TitansUFAClaimed20211$1,750,000$1,750,000$1,750,000$00.0%$0
LionsUFAExpired20211$1,750,000$1,750,000$1,750,000$500,00028.6%$500,000
LionsUFAActive20222$6,000,000$3,000,000$2,700,000$6,500,000108.3%$3,250,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Rams4$4,446,024$1,111,506$4,446,0240.0%$00.0%
Titans0$1,750,000$0$00.0%$1,750,0000.0%
Lions3$7,000,000$2,333,333$6,500,0000.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusRoster BonusPer Game Roster BonusWorkout BonusOther BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2017Rams$465,000$162,006$0$0$0$0$0$627,0060.4%$1,113,024
2018Rams$555,000$162,006$0$0$0$0$0$717,0060.4%$555,000
2019Rams$645,000$162,006$0$0$0$0$0$807,0060.4%$645,000
2020Rams$2,133,000$162,006$0$0$0$0$0$2,295,0061.1%$2,133,000
2021Lions$1,000,000$0$0$0$0$0$0$500,0000.3%$500,000
2022Lions$1,200,000$750,000$0$0$50,000$0$1,200,000$2,000,0000.9%$3,000,000
2023Lions$1,800,000$750,000$1,000,000$400,000$50,000$250,000$1,000,000$4,000,0001.8%$3,500,000
Total$7,798,000$2,148,024$1,000,000$400,000$100,000$250,000$2,200,000$10,946,024$11,446,024
Dead Money History
TeamYearCap ChargeCash Paid
Titans2021$1,250,000$1,250,000
Titans2021$500,000$500,000
Total$1,750,000$1,750,000

Statistics

YearGames PlayedGames InactiveSnapsRushingReceivingFumbles
InjuredHealthyOffenseSpecialAttYardsAvgTDRecYardsAvgTDTotalLost
2017160026.9%19.6%000.009889.8100
2018160055.5%20.2%284.002940213.9500
2019160043.3%11.4%5234.602132615.5100
2020160071.7%1.2%155.005261811.9200
2021120542.2%0.4%000.0010909.0200
2022142154.7%0.2%000.003847912.6300
2023170070.6%0.0%000.004060815.2500

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$9,245,000$3,000,000
Injury Adjusted$9,245,000$3,000,000
test
OTC Valuation $4.3M $8.7M $13M $17.4M $21.7M APY $5M $10M $15M $20M $25M $9,208,000 $5,035,348

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.